Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01660321 · ClinicalTrials.gov registry record · Phase 4
Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation
A Phase 4 study, sponsored by ParaPRO.
- Completed
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
NCT01660321 is a Phase 4 study that has completed, run by ParaPRO. The registered enrollment target is 26 participants.
The verdict
NCT01660321, a Phase 4 study, has completed, sponsored by ParaPRO.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
Study Summary
A pharmacokinetic and tolerance study of Natroba (spinosad) Topical Suspension, 0.9% in pediatric subjects 6 months to 4 years of age with an active head lice infestation.
Interventions
- DRUG spinosad
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01660321
The ClinicalTrials.gov registry entry for NCT01660321 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ParaPRO, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which spinosad is the first listed.
NCT01660321 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01660321 about?
NCT01660321 is a clinical study titled "Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation". A pharmacokinetic and tolerance study of Natroba (spinosad) Topical Suspension, 0.9% in pediatric subjects 6 months to 4 years of age with an active head lice infestation.
What is the current status of trial NCT01660321?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2011-09. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01660321?
The interventions under investigation include: spinosad (DRUG).
Who is sponsoring clinical trial NCT01660321?
This trial is sponsored by ParaPRO, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.